Key stats
About E FUND MANAGEMENT CO LTD CSI BRAND NAME DRUG INDUSTRY ETF
Home page
Inception date
Feb 3, 2021
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
E Fund Management Co., Ltd.
ISIN
CNE100004FG3
Tightly track the target index, and pursue the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.13%
Health Technology98.47%
Commercial Services0.62%
Process Industries0.01%
Producer Manufacturing0.01%
Non-Energy Minerals0.01%
Electronic Technology0.01%
Consumer Durables0.00%
Distribution Services0.00%
Bonds, Cash & Other0.87%
Cash0.82%
Miscellaneous0.05%
Stock breakdown by region
Asia97.87%
Europe2.13%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
516080 invests in stocks. The fund's major sectors are Health Technology, with 98.47% stocks, and Commercial Services, with 0.62% of the basket. The assets are mostly located in the Asia region.
516080 top holdings are WuXi AppTec Co., Ltd. Class A and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A, occupying 10.01% and 9.97% of the portfolio correspondingly.
516080 assets under management is 434.76 M CNY. It's risen 2.75% over the last month.
516080 fund flows account for 83.73 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 516080 doesn't pay dividends to its holders.
516080 shares are issued by E Fund Management Co., Ltd. under the brand E Fund. The ETF was launched on Feb 3, 2021, and its management style is Passive.
516080 expense ratio is 0.20% meaning you'd have to pay 0.20% of your investment to help manage the fund.
516080 follows the CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
516080 invests in stocks.
516080 price has risen by 3.75% over the last month, and its yearly performance shows a 27.88% increase. See more dynamics on 516080 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 3.79% over the last month, showed a 7.00% increase in three-month performance and has increased by 30.34% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 3.79% over the last month, showed a 7.00% increase in three-month performance and has increased by 30.34% in a year.
516080 trades at a premium (0.02%) meaning the ETF is trading at a higher price than the calculated NAV.